{
    "id": "0944",
    "question": "Two days after admission to the hospital for treatment of acute myelogenous leukemia, a 35-year-old man develops nausea, vomiting, fatigue, and muscle cramps. He has a history of diet-controlled type 2 diabetes mellitus. He has smoked one-half pack of cigarettes daily for 15 years and reports occasionally using marijuana. His temperature is 38.7\u00b0C (101.1\u00b0F), pulse is 85/min, respirations are 25/min, and blood pressure is 110/65 mm Hg. Laboratory studies show:\nLeukocyte count 16,000/mm3\nHemoglobin 13.4 g/dL\nPlatelet count 180,000/mm3\nSerum\nNa+ 134 mEq/L\nK+ 5.9 mEq/L\nCl- 101 mEq/L\nHCO3- 24 mEq/L\nUrea nitrogen 27 mg/dL\nUric acid 11.2 mg/dL\nCreatinine 2.2 mg/dL\nGlucose 134 mg/dL\nCa2+ 6.8 mg/dL\nMg2+ 1.8 g/dL\nPhosphorus 8.9 mg/dL\nWhich of the following would have been most effective in preventing this patient's current symptoms?\"",
    "options": {
        "A": "Urine alkalinization",
        "B": "Rasburicase",
        "C": "Allopurinol",
        "D": "Intravenous hydration"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To address this patient's symptoms, we need to consider the underlying cause of his current condition. The patient has acute myelogenous leukemia, which can lead to tumor lysis syndrome (TLS) due to the rapid breakdown of cancer cells. TLS is characterized by hyperkalemia, hyperuricemia, hyperphosphatemia, and hypocalcemia. The patient's symptoms of nausea, vomiting, fatigue, and muscle cramps are consistent with TLS. Given the patient's laboratory results, the most concerning abnormality is the hyperkalemia (K+ 5.9 mEq/L), which can lead to cardiac arrhythmias and even cardiac arrest. Urine alkalinization (A) is not the most effective option in this scenario as it would not directly address the hyperkalemia. Rasburicase (B) is an enzyme that breaks down uric acid, but it would not address the hyperkalemia. Allopurinol (C) is a xanthine oxidase inhibitor used to prevent tumor lysis syndrome, but it would not be effective in this scenario as the patient already has a high uric acid level. Intravenous hydration (D) is the most effective option in preventing TLS and managing hyperkalemia. It helps to increase renal excretion of potassium and reduce the risk of cardiac arrhythmias. The patient is also at risk of dehydration due to vomiting and nausea, so intravenous hydration is essential to ensure adequate fluid status and prevent further electrolyte imbalances. Therefore, the most effective option in preventing this patient's current symptoms is intravenous hydration.\", \"answer_choice\": \"D\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 57.2804536819458
}